What to do with an abnormal PSA test

Stacy Loeb; William J. Catalona

doi:10.1634/theoncologist.2007-0139

What to do with an abnormal PSA test

Stacy Loeb, William J. Catalona

Urology

Research output: Contribution to journal › Review article › peer-review

48 Scopus citations

Abstract

For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements.

Original language	English (US)
Pages (from-to)	299-305
Number of pages	7
Journal	Oncologist
Volume	13
Issue number	3
DOIs	https://doi.org/10.1634/theoncologist.2007-0139
State	Published - Mar 2008

Keywords

Detection
PSA
Prognosis
Prostate cancer
Prostate-specific antigen
Screening

ASJC Scopus subject areas

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1634/theoncologist.2007-0139

Cite this

@article{2bc2c5ff668e4e7280a72f39c69d6536,

title = "What to do with an abnormal PSA test",

abstract = "For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements.",

keywords = "Detection, PSA, Prognosis, Prostate cancer, Prostate-specific antigen, Screening",

author = "Stacy Loeb and Catalona, {William J.}",

year = "2008",

month = mar,

doi = "10.1634/theoncologist.2007-0139",

language = "English (US)",

volume = "13",

pages = "299--305",

journal = "Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "3",

}

TY - JOUR

T1 - What to do with an abnormal PSA test

AU - Loeb, Stacy

AU - Catalona, William J.

PY - 2008/3

Y1 - 2008/3

N2 - For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements.

AB - For more than a decade, prostate-specific antigen (PSA) has been used for prostate cancer screening. Over the years, this screening has been continually refined, including investigation into the use of lower total PSA thresholds, PSA isoforms, and PSA kinetics. This review describes the evolution of prostate cancer screening and provides clinical insights into the informed use of PSA and its adjunctive measurements.

KW - Detection

KW - PSA

KW - Prognosis

KW - Prostate cancer

KW - Prostate-specific antigen

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=43549084795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549084795&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2007-0139

DO - 10.1634/theoncologist.2007-0139

M3 - Review article

C2 - 18378540

AN - SCOPUS:43549084795

SN - 1083-7159

VL - 13

SP - 299

EP - 305

JO - Oncologist

JF - Oncologist

IS - 3

ER -

What to do with an abnormal PSA test

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this